Cargando…
Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study
BACKGROUND: Inhaled corticosteroids (ICS) are a prevailing treatment option for COPD patients but recent guidelines have relegated their use predominantly to patients with frequent exacerbations. Yet large numbers of patients worldwide are currently treated with ICS-containing regimens. We wished to...
Autores principales: | Bloom, Chloe I, Douglas, Ian, Usmani, Omar S, Quint, Jennifer K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136662/ https://www.ncbi.nlm.nih.gov/pubmed/32308379 http://dx.doi.org/10.2147/COPD.S241568 |
Ejemplares similares
-
Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study [Corrigendum]
Publicado: (2020) -
Rational use of inhaled corticosteroids for the treatment of COPD
por: Quint, Jennifer K., et al.
Publicado: (2023) -
Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016
por: Bloom, Chloe I, et al.
Publicado: (2019) -
Inhaled corticosteroids, blood eosinophils, and FEV(1) decline in patients with COPD in a large UK primary health care setting
por: Whittaker, Hannah R, et al.
Publicado: (2019) -
Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021)